get a key
steadybase-$ company BWAY
account_id none on file
legal_name Brainsway Ltd.
ticker BWAY
cik 1505065
domain brainsway.com
entry_point_account_id none on file
name BrainsWay Ltd.
exchange Nasdaq
sector Health Care
hq Jerusalem, Israel
calls 2 filings 5 executives 8 family 0
why_nownone on file
calls
While I have spent a lot of time today discussing our top-line performance and future growth drivers, our team has done a tremendous job balancing our expense management while generating this high level of revenue growth.

May 13, 2025 / receipt, needs a key / Hadar Levy, CEO | earnings call 2025-05-13 | transcript 4cb2fd47-471b-45ef-8b78-e3b9b96420ff | chars 7009-7230 | segment 7

Sales and marketing expenses for the third quarter of 2022 were $4.8 million, compared to $4 million for the third quarter of 2021. These increases are due primarily to increased cost of travel, marketing events in the quarter, and increased personnel to support our customers.

Nov 16, 2022 / receipt, needs a key / Chris Bagnacco, CEO | earnings call 2022-11-16 | transcript d24b2ddb-76c5-46d3-a483-1ba5b24f5058 | chars 14652-14929 | segment 14

filings
Hadar Levy | 52 | Chief Executive Officer

filing / Apr 20, 2026 / receipt

Ido Marom | 50 | Chief Financial Officer

filing / Apr 20, 2026 / receipt

Naomi Rozenfeld | 41 | Chief Marketing Officer

filing / Apr 20, 2026 / receipt

Ami Boehm | 56 | Chairman of the Board

filing / Apr 20, 2026 / receipt

Prof. Abraham Zangen | 55 | Director

filing / Apr 20, 2026 / receipt

executives
Ami Boehm Chairman of the Board - receipt
Chris Bagnacco CEO - receipt
Chris Warniakos CEO - receipt
Hadar Levy CEO - receipt
Ido Marom Chief Financial Officer - receipt
Naomi Rozenfeld Chief Marketing Officer - receipt
Prof. Abraham Zangen Director - receipt
Scott Arreglato CFO - receipt
familynone on file
upcoming
2026-11-10 earnings call scheduled ir
changesnone on file
mcp_package_hint
steadybase-$